• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向激活转录因子6可减少视网膜疾病模型中的病理性血管生成并改善视觉预后。

Targeting ATF6 reduces pathological neovascularization and improves visual outcomes in retinal disease models.

作者信息

Bradley Allyssa, Park Soyoung, Park Soyeon, Kim Kyle, Galdamez Angela, Min Hyejung, Diaz-Aguilar Monica Sophia, Hartnett M Elizabeth, Lee Eun-Jin, Lin Jonathan H

机构信息

Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.

Department of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.

出版信息

Sci Rep. 2025 Sep 26;15(1):33070. doi: 10.1038/s41598-025-15393-y.

DOI:10.1038/s41598-025-15393-y
PMID:41006433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12475287/
Abstract

Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6's causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases.

摘要

病理性视网膜新生血管形成是导致包括早产儿视网膜病变(ROP)、湿性年龄相关性黄斑变性(AMD)和糖尿病性视网膜病变在内的多种疾病视力丧失的原因。未折叠蛋白反应(UPR)是一种细胞内信号转导机制,由内质网应激激活,并上调许多蛋白质,包括血管生成因子如血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)。这表明UPR基因和信号通路可能驱动视网膜血管生成。在此,我们测试了UPR调节因子激活转录因子6(ATF6)在病理性和发育性视网膜血管生成中的作用。我们使用氧诱导视网膜病变(OIR)模型在Atf6基因敲除小鼠中诱导病理性视网膜新生血管形成,发现视觉功能显著保留,同时视网膜新生血管形成、内皮细胞增殖和UPR转录程序诱导减少。当我们通过眼内注射小分子Ceapin-A7化学阻断ATF6信号时,我们还观察到UPR基因的视网膜表达受到抑制。此外,在出生后第7天的Atf6基因敲除小鼠中,当视网膜血管系统因生理性眼内缺氧而发育时,在修剪和视网膜血管延伸方面存在短暂但显著的缺陷。总之,我们的结果证明了ATF6在发育性和病理性视网膜血管生成中的因果作用,并突出了其作为治疗靶点以保护视网膜新生血管疾病视力的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/2e6f4d8178fa/41598_2025_15393_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/4d3cecd0aea2/41598_2025_15393_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/5c491ec18cff/41598_2025_15393_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/185771f9c6c0/41598_2025_15393_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/5ff68d5e35d4/41598_2025_15393_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/2e6f4d8178fa/41598_2025_15393_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/4d3cecd0aea2/41598_2025_15393_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/5c491ec18cff/41598_2025_15393_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/185771f9c6c0/41598_2025_15393_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/5ff68d5e35d4/41598_2025_15393_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/12475287/2e6f4d8178fa/41598_2025_15393_Fig5_HTML.jpg

相似文献

1
Targeting ATF6 reduces pathological neovascularization and improves visual outcomes in retinal disease models.靶向激活转录因子6可减少视网膜疾病模型中的病理性血管生成并改善视觉预后。
Sci Rep. 2025 Sep 26;15(1):33070. doi: 10.1038/s41598-025-15393-y.
2
Serine supplementation suppresses hypoxia-induced pathological retinal angiogenesis.补充丝氨酸可抑制缺氧诱导的病理性视网膜血管生成。
Theranostics. 2025 Apr 9;15(11):5087-5105. doi: 10.7150/thno.105299. eCollection 2025.
3
Transcriptomic Profiling of Small Molecule Atf6 Modulators in the Retina.视网膜中小分子Atf6调节剂的转录组分析
FASEB J. 2025 Aug 31;39(16):e70940. doi: 10.1096/fj.202501459R.
4
Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1α.参考文献1氧化还原活性通过调节缺氧诱导因子-1α(HIF-1α)的转录激活来调控视网膜新生血管形成。
FASEB J. 2025 Feb 15;39(3):e70348. doi: 10.1096/fj.202401989RR.
5
Role of acyl-coenzyme A: cholesterol transferase 1 (ACAT1) in retinal neovascularization.酰基辅酶 A:胆固醇转移酶 1(ACAT1)在视网膜新生血管中的作用。
J Neuroinflammation. 2023 Jan 23;20(1):14. doi: 10.1186/s12974-023-02700-5.
6
Sorting nexin 3 promotes ischemic retinopathy through RIP1- and RIP3-mediated myeloid cell necroptosis and mitochondrial fission.分选连接蛋白3通过RIP1和RIP3介导的髓样细胞坏死性凋亡和线粒体分裂促进缺血性视网膜病变。
Proc Natl Acad Sci U S A. 2025 Sep 16;122(37):e2426578122. doi: 10.1073/pnas.2426578122. Epub 2025 Sep 9.
7
ATF6 Alleviates Endothelial Inflammation Following Extended Hepatectomy Through Inhibition of TRIM10/NF-κB Signaling.ATF6通过抑制TRIM10/NF-κB信号通路减轻扩大肝切除术后的内皮炎症。
FASEB J. 2025 Aug 31;39(16):e70933. doi: 10.1096/fj.202402197RRR.
8
Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair.靶向增生性视网膜病变:精氨酸酶 1 限制脉络膜新生血管形成并促进血管生成修复。
Cell Death Dis. 2022 Aug 29;13(8):745. doi: 10.1038/s41419-022-05196-8.
9
Robo4 inhibits neovascularization in oxygen-induced retinopathy by regulating ARF6 and VEGF.Robo4通过调节ARF6和VEGF抑制氧诱导性视网膜病变中的新生血管形成。
Hum Cell. 2025 Aug 8;38(5):140. doi: 10.1007/s13577-025-01270-3.
10
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis.组蛋白去乙酰化酶3介导视网膜内皮细胞代谢重编程和血管生成。
Acta Pharmacol Sin. 2025 Sep 29. doi: 10.1038/s41401-025-01642-3.

本文引用的文献

1
Vulnerability of the Nrl Cone-Dominant Retina to Endoplasmic Reticulum Stress.Nrl 视锥细胞主导型视网膜对内质网应激的易损性。
Adv Exp Med Biol. 2025;1468:319-324. doi: 10.1007/978-3-031-76550-6_53.
2
Mutations in unfolded protein response regulator ATF6 cause hearing and vision loss syndrome.未折叠蛋白反应调节因子ATF6的突变会导致听力和视力丧失综合征。
J Clin Invest. 2025 Feb 3;135(3):e175562. doi: 10.1172/JCI175562.
3
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease.内质网:视网膜健康与疾病中的稳态和串扰。
Prog Retin Eye Res. 2024 Jan;98:101231. doi: 10.1016/j.preteyeres.2023.101231. Epub 2023 Dec 12.
4
PERK Inhibition Suppresses Neovascularization and Protects Neurons During Ischemia-Induced Retinopathy.PERK 抑制在缺血性视网膜病变期间抑制血管新生和保护神经元。
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):17. doi: 10.1167/iovs.64.11.17.
5
Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity.激光与抗血管内皮生长因子:治疗性早产儿视网膜病变的范式转变
Ophthalmol Ther. 2023 Oct;12(5):2241-2252. doi: 10.1007/s40123-023-00744-7. Epub 2023 Jun 19.
6
Pathophysiology of Retinopathy of Prematurity.早产儿视网膜病变的病理生理学。
Annu Rev Vis Sci. 2023 Sep 15;9:39-70. doi: 10.1146/annurev-vision-093022-021420. Epub 2023 May 10.
7
Mitochondria and Endoplasmic Reticulum Stress in Retinal Organoids from Patients with Vision Loss.线粒体和内质网应激在视力丧失患者的视网膜类器官中的作用。
Am J Pathol. 2023 Nov;193(11):1721-1739. doi: 10.1016/j.ajpath.2022.12.002. Epub 2022 Dec 17.
8
Retinopathy of prematurity.早产儿视网膜病变
Dev Med Child Neurol. 2023 May;65(5):625-631. doi: 10.1111/dmcn.15468. Epub 2022 Nov 21.
9
Retinoid signaling regulates angiogenesis and blood-retinal barrier integrity in neonatal mouse retina.维甲酸信号通路调控新生小鼠视网膜中的血管生成和血视网膜屏障完整性。
Microcirculation. 2022 Apr;29(3):e12752. doi: 10.1111/micc.12752. Epub 2022 Mar 5.
10
Retinopathy of prematurity: a review of epidemiology and current treatment strategies.早产儿视网膜病变:流行病学及当前治疗策略综述
Clin Exp Pediatr. 2022 Mar;65(3):115-126. doi: 10.3345/cep.2021.00773. Epub 2021 Oct 12.